MCID: SCL003
MIFTS: 46

Social Phobia malady

Categories: Mental diseases

Aliases & Classifications for Social Phobia

Aliases & Descriptions for Social Phobia:

Name: Social Phobia 12 14
Phobic Anxiety Disorder 69
Phobic Disorders 42
Phobia, Social 69
Phobia Social 52

Classifications:



External Ids:

Disease Ontology 12 DOID:11257
ICD9CM 35 300.23
MeSH 42 D010698
NCIt 47 C34927
UMLS 69 C0031572

Summaries for Social Phobia

Disease Ontology : 12 A phobic disorder that involves social anxiety occurring only in specific public or social situations, interactions with others or being evaluated or scrutinized by other people.

MalaCards based summary : Social Phobia, also known as phobic anxiety disorder, is related to personality disorder and schizophrenia. An important gene associated with Social Phobia is MAOA (Monoamine Oxidase A), and among its related pathways/superpathways are Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways and Serotonergic synapse. The drugs Cycloserine and Norepinephrine have been mentioned in the context of this disorder. Affiliated tissues include testes, brain and amygdala, and related phenotypes are behavior/neurological and endocrine/exocrine gland

Related Diseases for Social Phobia

Diseases related to Social Phobia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 103)
id Related Disease Score Top Affiliating Genes
1 personality disorder 30.2 CCK DRD2 MAOA SLC6A4
2 schizophrenia 29.0 CCK DRD2 HTR3A MAOA PRL SLC6A4
3 phobic disorder 12.1
4 anxiety disorder 10.5
5 avoidant personality disorder 10.5
6 panic disorder 10.4
7 agoraphobia 10.3
8 generalized anxiety disorder 10.3
9 obsessive-compulsive disorder 10.2
10 conjunctival pigmentation 10.2 MAOA SLC6A4
11 neurogenic bladder 10.2 MAOA SLC6A4
12 tinea pedis 10.2 MAOA SLC6A4
13 intrahepatic gall duct cancer 10.1 MAOA SLC6A4
14 mutism 10.1
15 hypoglycemic coma 10.1 MAOA SLC6A4
16 luxation of globe 10.1 PRL SLC6A4
17 anodontia 10.1 HTR3A SLC6A4
18 dyspepsia 10.1 CCK PRL
19 multiple personality disorder 10.1 MAOA SLC6A4
20 keratosis 10.1 MAOA SLC6A4
21 chronic eosinophilic pneumonia 10.1 MAOA PRL SLC6A4
22 deafness, autosomal recessive 1a 10.0 CCK PTK7
23 rhinoscleroma 10.0 DRD2 PRL
24 scleral staphyloma 10.0 CCK HTR3A
25 lung occult small cell carcinoma 10.0 DRD2 PRL
26 pfeiffer rockelein syndrome 10.0 DRD2 PRL
27 alzheimer disease 17 10.0 PRL SLC6A4
28 intracranial cavernous angioma 10.0 DRD2 SLC6A4
29 adult brainstem astrocytoma 10.0 MAOA PTK7 SLC6A4
30 renpenning syndrome 10.0 HTR3A MAOA SLC6A4
31 kidney pelvis papillary carcinoma 10.0 MAOA PTK7 SLC6A4
32 splenic abscess 10.0 DRD2 SLC6A4
33 pulmonary neuroendocrine tumor 10.0 DRD2 PRL
34 hepatitis b reinfection following liver transplantation 10.0 HTR3A MAOA SLC6A4
35 euthyroid sick syndrome 10.0 DRD2 SLC6A4
36 apperceptive agnosia 10.0 DRD2 SLC6A4
37 waardenburg's syndrome 10.0 DRD2 SLC6A4
38 atrial fibrillation, familial, 10 10.0 HTR3A MAOA SLC6A4
39 infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovasuclar malformations 10.0 DRD2 PRL
40 phobia, specific 10.0
41 body dysmorphic disorder 10.0
42 strabismus 10.0
43 separation anxiety disorder 10.0
44 acute contagious conjunctivitis 9.9 CCK DRD2
45 interstitial emphysema 9.9 DRD2 SLC6A4
46 hemolytic anemia, cd59-mediated, with or without immune-mediated polyneuropathy 9.9 CCK PRL SLC6A4
47 bile acid synthesis defect, congenital, 4 9.9 DRD2 PRL
48 cold-induced sweating syndrome 2 9.9 DRD2 PRL
49 lichen disease 9.9 MAOA SLC6A4
50 deafness, autosomal recessive 20 9.9 CCK HTR3A SLC6A4

Comorbidity relations with Social Phobia via Phenotypic Disease Network (PDN):


Anxiety Disorder Dysthymic Disorder

Graphical network of the top 20 diseases related to Social Phobia:



Diseases related to Social Phobia

Symptoms & Phenotypes for Social Phobia

MGI Mouse Phenotypes related to Social Phobia:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 9.73 CCK DRD2 HTR3A MAOA PRL SLC6A4
2 endocrine/exocrine gland MP:0005379 9.55 HTR3A PRL SLC6A4 CCK DRD2
3 homeostasis/metabolism MP:0005376 9.43 CCK DRD2 HTR3A MAOA PRL SLC6A4
4 nervous system MP:0003631 9.17 CCK DRD2 HTR3A MAOA PRL PTK7

Drugs & Therapeutics for Social Phobia

Drugs for Social Phobia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 204)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cycloserine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 68-41-7 401 6234
2
Norepinephrine Approved Phase 4,Phase 3 51-41-2 439260
3
Citalopram Approved Phase 4,Phase 2,Phase 3,Phase 1 59729-33-8 2771
4
Paroxetine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 61869-08-7 43815
5
Clonazepam Approved, Illicit Phase 4 1622-61-3 2802
6
Sertraline Approved Phase 4,Phase 3,Phase 2,Phase 1 79617-96-2 68617
7 Piracetam Approved Phase 4,Phase 2 7491-74-9
8
Tiagabine Approved Phase 4 115103-54-3 60648
9
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
10
Acamprosate Approved, Investigational Phase 4 77337-76-9 71158
11
Ethanol Approved Phase 4,Phase 2 64-17-5 702
12
Propranolol Approved, Investigational Phase 4,Phase 2,Phase 3 525-66-6 4946
13
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
14
Dopamine Approved Phase 4,Phase 3,Phase 2 51-61-6, 62-31-7 681
15
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
16
Topiramate Approved Phase 4 97240-79-4 5284627
17
Acetylcholine Approved Phase 4 51-84-3 187
18
Ketamine Approved, Vet_approved Phase 4,Early Phase 1 6740-88-1 3821
19
Vortioxetine Approved Phase 4 508233-74-7 9966051
20
Tetracaine Approved, Vet_approved Phase 4 94-24-6 5411
21 Psychotropic Drugs Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
22 Antidepressive Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
23 Antidepressive Agents, Second-Generation Phase 4,Phase 2,Phase 3,Phase 1
24 Neurotransmitter Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
25 Neurotransmitter Uptake Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
26
Serotonin Phase 4,Phase 2,Phase 3,Phase 1 50-67-9 5202
27 Serotonin Agents Phase 4,Phase 2,Phase 3,Phase 1
28 Serotonin Uptake Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
29 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
30 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
31 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
32 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
33 Antitubercular Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
34 Renal Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
35 Antiparkinson Agents Phase 4,Phase 2,Phase 3,Phase 1
36 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1
37 Cholinergic Agents Phase 4,Phase 2,Phase 3,Phase 1
38 Cholinergic Antagonists Phase 4,Phase 2,Phase 3,Phase 1
39 Muscarinic Antagonists Phase 4,Phase 2,Phase 3,Phase 1
40 Parasympatholytics Phase 4,Phase 2,Phase 3,Phase 1
41 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
42 Serotonin 5-HT1 Receptor Agonists Phase 4
43 Antipsychotic Agents Phase 4,Phase 3,Phase 2,Early Phase 1
44 Central Nervous System Depressants Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
45 Quetiapine Fumarate Phase 4,Phase 3,Phase 2,Early Phase 1 111974-72-2
46 Tranquilizing Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
47 Cytochrome P-450 CYP2D6 Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
48 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
49 Anticonvulsants Phase 4,Phase 2,Phase 3
50 GABA Agents Phase 4,Phase 2,Phase 1

Interventional clinical trials:

(show top 50) (show all 334)
id Name Status NCT ID Phase
1 The Use of Quetiapine (Seroquel) in the Treatment of Social Phobia: Public Speaking Environment Completed NCT00407199 Phase 4
2 RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and Placebo Completed NCT00184106 Phase 4
3 D-Cycloserine Enhancement of Exposure in Social Phobia Completed NCT00633984 Phase 4
4 Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder Completed NCT00282828 Phase 4
5 Nefazodone in the Treatment of Social Phobia Completed NCT00231348 Phase 4
6 Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents Completed NCT01160588 Phase 4
7 Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder Completed NCT00872131 Phase 4
8 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder Completed NCT01316302 Phase 4
9 Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder Completed NCT00265109 Phase 4
10 Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder Completed NCT00767871 Phase 4
11 Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism Completed NCT00246441 Phase 4
12 Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder Completed NCT00208741 Phase 4
13 Escitalopram in Patients With Social Anxiety Disorder Completed NCT00902226 Phase 4
14 Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults Completed NCT01224067 Phase 4
15 Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder Completed NCT00190879 Phase 4
16 Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety Completed NCT00177008 Phase 4
17 Primary Care Intervention Strategy for Anxiety Disorders Completed NCT00347269 Phase 4
18 Acamprosate in Alcoholics With Comorbid Anxiety or Depression Completed NCT00330174 Phase 4
19 Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP) Recruiting NCT00182455 Phase 4
20 Brief Intervention to Reduce Fear of Public Speaking Recruiting NCT02790736 Phase 4
21 A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder Recruiting NCT03078270 Phase 4
22 Ketamine Infusion for Adolescent Depression and Anxiety Recruiting NCT02579928 Phase 4
23 Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders Active, not recruiting NCT00182533 Phase 4
24 Comparison of Routine IM Influenza Immunization and Administration by Jet-injector in Healthy Young Adults Active, not recruiting NCT03150537 Phase 4
25 Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder Active, not recruiting NCT02294305 Phase 4
26 Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity Active, not recruiting NCT01863459 Phase 4
27 Effect of Including Synera® in Discussions on Dialysis Access Conversion in Patients With Needle Phobias Terminated NCT01623583 Phase 4
28 Transfer of Manualized Cognitive-Behavioral Therapy (CBT) for Social Phobia Into Clinical Practice Unknown status NCT01388231 Phase 2, Phase 3
29 Study of Escitalopram in the Treatment of Specific Phobia Completed NCT00121069 Phase 2, Phase 3
30 Treatment of Childhood Social Phobia Completed NCT00043537 Phase 3
31 Residential Cognitive and Interpersonal Therapy for Social Phobia Completed NCT00326430 Phase 2, Phase 3
32 A Comparison Between Internet Therapy and Group Therapy for Social Phobia - A Trial Using Cognitive Behavioural Therapy Completed NCT00564967 Phase 3
33 Treatment of Social Phobia and Panic Disorder in Adults Completed NCT00619138 Phase 3
34 Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia Completed NCT00515879 Phase 3
35 Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety Completed NCT00958880 Phase 3
36 Facilitation of Fear Extinction With Yohimbine Hydrochloride in Phobic Participants Completed NCT00734422 Phase 2, Phase 3
37 Long-term Study Of Paroxetine in Women and Men Completed NCT00264654 Phase 3
38 Noradrenergic Manipulation and Virtual Reality Exposure Therapy in Phobic Participants Completed NCT02007694 Phase 2, Phase 3
39 D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia Completed NCT01102803 Phase 3
40 Social Anxiety Disorder Study Of Paroxetine Completed NCT00318669 Phase 3
41 Flushing in Social Anxiety Disorder on Seroquel Completed NCT00773162 Phase 3
42 Child and Adolescent Anxiety Disorders (CAMS) Completed NCT00052078 Phase 3
43 Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder Completed NCT00260533 Phase 2, Phase 3
44 Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder Completed NCT00074802 Phase 3
45 Quetiapine in Social Anxiety Disorder Completed NCT00215254 Phase 2, Phase 3
46 Treatment for Anxiety in Children Completed NCT00000389 Phase 3
47 Computerized Cognitive Behavioral Therapy for Childhood Anxiety in Community Health Centers Completed NCT01416805 Phase 3
48 St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD) Completed NCT00118833 Phase 2, Phase 3
49 Virtual Reality Exposure Therapy in Agoraphobic Participants Completed NCT00734370 Phase 2, Phase 3
50 Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD) Completed NCT02622958 Phase 3

Search NIH Clinical Center for Social Phobia

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: phobic disorders

Genetic Tests for Social Phobia

Anatomical Context for Social Phobia

MalaCards organs/tissues related to Social Phobia:

39
Testes, Brain, Amygdala, Heart, Cortex, Pituitary, Hypothalamus

Publications for Social Phobia

Articles related to Social Phobia:

(show top 50) (show all 602)
id Title Authors Year
1
Psychometric properties of the mini-social phobia inventory (Mini-SPIN) in a large online treatment-seeking sample. ( 27046641 )
2016
2
The effect of Interaction Anxiousness Scale and Brief Social Phobia Scale for screening social anxiety disorder in college students: a study on discriminative validity. ( 27935389 )
2016
3
Autonomic markers associated with generalized social phobia symptoms: heart rate variability and salivary alpha-amylase. ( 27892761 )
2016
4
Social Phobia: The Role of In-Situation Safety Behaviors in Maintaining Anxiety and Negative Beliefs - Republished Article. ( 27816079 )
2016
5
Retracted: Combined Case of Blood-Injury-Injection Phobia and Social Phobia: Behavior Therapy Management and Effectiveness through Tilt Test. ( 27722005 )
2016
6
Virtual reality exposure using three-dimensional images for the treatment of social phobia. ( 26561376 )
2016
7
Selective Mutism: The Fraternal Twin of Childhood Social Phobia. ( 27089281 )
2016
8
Hypochondriasis Differs From Panic Disorder and Social Phobia: Specific Processes Identified Within Patient Groups. ( 27805984 )
2016
9
Community-Based Validation of the Social Phobia Screener (SOPHS). ( 26939801 )
2016
10
Assimilation, reflexivity, and therapist responsiveness in group psychotherapy for social phobia: A case study. ( 27092848 )
2016
11
Factor solutions of the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS) in a Swedish population. ( 27894213 )
2016
12
No effects of psychosocial stress on memory retrieval in non-treated young students with Generalized Social Phobia. ( 27464065 )
2016
13
Examination of the Correlation Between Internet Addiction and Social Phobia in Adolescents. ( 27561297 )
2016
14
Attentional mechanisms of social perception are biased in social phobia. ( 27131909 )
2016
15
Social Phobia Is Associated with Delayed Onset of Chickenpox, Measles, and Mumps Infections. ( 28082921 )
2016
16
Correction: The Neuroanatomical Basis of Panic Disorder and Social Phobia in Schizophrenia: A Voxel Based Morphometric Study. ( 25906143 )
2015
17
Comparison of automatical thoughts among generalized anxiety disorder, major depressive disorder and generalized social phobia patients. ( 26241548 )
2015
18
The neuroanatomical basis of panic disorder and social phobia in schizophrenia: a voxel based morphometric study. ( 25774979 )
2015
19
Social Phobia and Educational and Interpersonal Impairments in Adolescence: A Prospective Study. ( 26514560 )
2015
20
Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia. ( 26288643 )
2015
21
Latent dimensions of social anxiety disorder: A re-evaluation of the Social Phobia Inventory (SPIN). ( 26454660 )
2015
22
Intensive Group-Based CBT for Child Social Phobia: A Pilot Study. ( 25892171 )
2015
23
Social anxiety disorders in clinical practice: differentiating social phobia from avoidant personality disorder. ( 26129819 )
2015
24
Correction: Avoidant Personality Disorder versus Social Phobia: The Significance of Childhood Neglect. ( 25978045 )
2015
25
An experimental investigation of the functional relationship between social phobia and cigarette smoking. ( 25576952 )
2015
26
Social phobia and quality of life in morbidly obese patients before and after bariatric surgery. ( 25863007 )
2015
27
Avoidant Personality Disorder versus Social Phobia: The Significance of Childhood Neglect. ( 25815817 )
2015
28
Developmental Differences in Functioning in Youth With Social Phobia. ( 26630122 )
2015
29
Attachment styles in patients with avoidant personality disorder compared with social phobia. ( 26332087 )
2015
30
Behavioral treatment of social phobia in youth: Does parent education training improve the outcome? ( 25727679 )
2015
31
Reprint of: Social phobia and other psychiatric problems in children with strabismus. ( 26049893 )
2015
32
Homicidal/violent thoughts, suicidal ideation and violent behavior in adolescents with social phobia in Metropolitan Lima, PerA_. ( 24771716 )
2014
33
Comparing Short Forms of the Social Interaction Anxiety Scale and the Social Phobia Scale. ( 24932648 )
2014
34
Hypnosis aided fixed role therapy for social phobia: a case report. ( 24938079 )
2014
35
Biased attention to threat in paediatric anxiety disorders (generalized anxiety disorder, social phobia, specific phobia, separation anxiety disorder) as a function of 'distress' versus 'fear' diagnostic categorization. ( 23591000 )
2014
36
Social phobia among long-term internally displaced persons: An epidemiological study of adults in two internally displaced person settlements in Sudan. ( 25540300 )
2014
37
The dutch social interaction anxiety scale and the social phobia scale: reliability, validity, and clinical utility. ( 24701560 )
2014
38
Have we met before? Neural correlates of emotional learning in women with social phobia. ( 24758944 )
2014
39
Prevalence and disability of comorbid social phobia and obsessive-compulsive disorder in patients with panic disorder and generalized anxiety disorder. ( 25289805 )
2014
40
The contribution of the therapist's competence in the treatment of adolescents with generalized social phobia. ( 25340895 )
2014
41
Baseline Patient Characteristics Predicting Outcome and Attrition in Cognitive Therapy for Social Phobia: Results from a Large Multicentre Trial. ( 25504802 )
2014
42
The Social Interaction Anxiety Scale (SIAS) and the Social Phobia Scale (SPS): A Comparison of Two Short-Form Versions. ( 24978134 )
2014
43
Of 'disgrace' and 'pain' - corticolimbic interaction patterns for disorder-relevant and emotional words in social phobia. ( 25396729 )
2014
44
Imagery rescripting as a stand-alone treatment for patients with social phobia: a case series. ( 24161701 )
2014
45
Hypervigilance and avoidance in visual attention in children withA social phobia. ( 24103693 )
2014
46
Early adolescent symptoms of social phobia prospectively predict alcohol use. ( 25343649 )
2014
47
Bruxism and oral parafunctional hyperactivity in social phobia outpatients. ( 25238249 )
2014
48
Children with social phobia have lower quality friendships than children with other anxiety disorders. ( 25337769 )
2014
49
Subliminal cues bias perception of facial affect in patients with social phobia: evidence for enhanced unconscious threat processing. ( 25136307 )
2014
50
Randomized Controlled Trial of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy for Social Phobia: Outcomes and Moderators. ( 24999670 )
2014

Variations for Social Phobia

Expression for Social Phobia

Search GEO for disease gene expression data for Social Phobia.

Pathways for Social Phobia

GO Terms for Social Phobia

Cellular components related to Social Phobia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 axon GO:0030424 8.8 CCK DRD2 HTR3A

Biological processes related to Social Phobia according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 circadian rhythm GO:0007623 9.37 PRL SLC6A4
2 response to drug GO:0042493 9.33 DRD2 PRL SLC6A4
3 response to nutrient GO:0007584 9.32 PRL SLC6A4
4 cellular response to retinoic acid GO:0071300 9.26 PTK7 SLC6A4
5 response to cocaine GO:0042220 8.96 DRD2 HTR3A
6 response to ethanol GO:0045471 8.8 DRD2 HTR3A PRL

Sources for Social Phobia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....